a Department of Pharmaceutics, School of Pharmacy , Shenyang Pharmaceutical University , Shenyang , P.R. China.
b Department of Traditional Chinese Medicine, School of Pharmacy , Shenyang Pharmaceutical University , Shenyang , P.R. China.
Drug Deliv. 2018 Nov;25(1):1826-1839. doi: 10.1080/10717544.2018.1482975.
Nanoparticles (NPs) have proven to be effective drug carriers in diagnosis and therapy of cancer. But, they faced a contradictory issue that NPs with large size appear weak tumor penetration, meanwhile small size resulted in poor tumor retention. Herein, we fabricated doxorubicin conjugated carbon dots (CDs-DOX) and indocyanine green (ICG)-loaded liposomes (ICG-LPs) named CDs-ICG-LPs using a modified reverse phase evaporation process, and with high incorporation in the aqueous core. The CDs-ICG-LPs exhibited good monodispersity, excellent fluorescence/size stability, and consistent spectra characteristics compared with free ICG or DOX. Moreover, the CDs-ICG-LPs showed higher temperature response, faster DOX release under laser irradiation. In the meantime, the fluorescence of DOX and ICG in CDs-ICG-LPs was also visualized for the process of subcellular location in vitro. In comparison with chemo or photothermal treatment alone, the combined treatment of CDs-ICG-LPs with laser irradiation synergistically induced the apoptosis and death of DOX-sensitive HepG2 cells. In vivo antitumor activities demonstrated CDs-ICG-LPs could reach higher antitumor activity compared with CDs-DOX and ICG-LPs for H22 tumor cells, and suppressed H22 tumor growth in vivo. Notably, no systemic toxicity occurrence was observed after repeated dose of CDs-ICG-LPs with laser irradiation. Hence, the well-defined CDs-ICG-LPs exhibited great potential in targeting cancer imaging and chemo-photothermal therapy.
纳米粒子(NPs)已被证明在癌症的诊断和治疗中是有效的药物载体。但是,它们面临着一个矛盾的问题,即大尺寸的 NPs 表现出较弱的肿瘤穿透性,而小尺寸则导致肿瘤滞留性差。在此,我们使用改良的反相蒸发法制备了阿霉素偶联碳点(CDs-DOX)和载有吲哚菁绿(ICG)的脂质体(ICG-LPs),并将其高浓度地包裹在水核中。与游离的 ICG 或 DOX 相比,CDs-ICG-LPs 表现出良好的单分散性、优异的荧光/粒径稳定性和一致的光谱特征。此外,CDs-ICG-LPs 表现出更高的温度响应性,在激光照射下更快地释放 DOX。同时,在体外细胞亚定位过程中也可以观察到 CD-ICG-LPs 中 DOX 和 ICG 的荧光。与单独化疗或光热治疗相比,CDs-ICG-LPs 联合激光照射协同诱导 DOX 敏感的 HepG2 细胞凋亡和死亡。体内抗肿瘤活性表明,与 CDs-DOX 和 ICG-LPs 相比,CDs-ICG-LPs 对 H22 肿瘤细胞具有更高的抗肿瘤活性,并能抑制体内 H22 肿瘤的生长。值得注意的是,经多次激光照射后,CDs-ICG-LPs 并未出现全身毒性。因此,这种明确的 CDs-ICG-LPs 在靶向癌症成像和化疗-光热治疗方面具有巨大的潜力。